Stay updated on Safety of CVL-231 in Schizophrenia: Clinical Trial

Sign up to get notified when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of CVL-231 in Schizophrenia: Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.4, indicating a small backend/content update to the page.
    Difference
    0.0%
    Check dated 2026-07-25T09:31:19.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Topic tags were updated to remove Schizophrenia and the related topics MedlinePlus Genetics. This change narrows the subject associations presented for the study on this page.
    Difference
    0.1%
    Check dated 2026-07-18T03:56:44.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.2 to v3.6.3, indicating a small patch or update to the page.
    Difference
    0.0%
    Check dated 2026-07-03T22:43:30.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous v3.6.0. This indicates a version update to the page rather than a substantive change to the study information.
    Difference
    0.0%
    Check dated 2026-06-27T00:33:59.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2026-06-12T16:14:59.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Results Submitted indicates that study results have been submitted. The page revision has been updated to v3.5.5, replacing the previous No Results Posted status and v3.5.4 revision.
    Difference
    0.1%
    Check dated 2026-06-05T12:09:38.000Z thumbnail image

Stay in the know with updates to Safety of CVL-231 in Schizophrenia: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.